Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Acta Neuropathologica Communications
|
December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature Genetics
|
April 11, 2017
Spatial heterogeneity in medulloblastoma
A Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature
|
July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A Northcott, Catherine Lee, Thomas Zichner, et al.
Acta Neuropathologica
|
November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature
|
February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S C Mack, H Witt, R M Piro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroups
David J H Shih, Paul A Northcott, Marc Remke, et al.
Cancer Cell
|
June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology
|
March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Nature
|
July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A Northcott, David J H Shih, John Peacock, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Acta Neuropathologica Communications
|
December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature Genetics
|
April 11, 2017
Spatial heterogeneity in medulloblastoma
A Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature
|
July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A Northcott, Catherine Lee, Thomas Zichner, et al.
Acta Neuropathologica
|
November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature
|
February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S C Mack, H Witt, R M Piro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroups
David J H Shih, Paul A Northcott, Marc Remke, et al.
Cancer Cell
|
June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology
|
March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Nature
|
July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A Northcott, David J H Shih, John Peacock, et al.
Page
of 7